NecstGen Contributing to the Future of CGT

24 April 2026, the Cell & Gene Therapy Community Gathers at PLNT Leiden for Sharp Discussions, Hands-on Workshops, and Practical Insights from Active CGT Programmes.

On 24 April 2026, the Cell & Gene Therapy community gathers at PLNT Leiden for the Future of CGT.

NecstGen is contributing to this conference together with partners across the ecosystem: Health~Holland, JPP – Life Sciences Marketing & BD, Leiden Bio Science Park, OVBSP Leiden, and host PLNT Leiden.

The programme is built for teams actively working in CGT. Expect case studies from real CGT projects with concrete lessons, breakout tracks covering biotech, manufacturing, regulatory, and clinical development, workshops focused on building practical skills, and a partnering setting structured for honest conversations and new collaborations.

Speakers bring direct experience from CGT ventures, clinical development, and the broader ecosystem, covering topics such as financing structures, investor alignment, post-deal continuity, and the path from innovation to patient impact.

If you are building, backing, or scaling in CGT, the content is relevant to your work.

More information on this event & tickets can be found here: https://futureofcgt.com/

The First Stages of CAR T Cell Therapy Development

The First Stages of CAR T Cell Therapy Development

Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...

Webinar LV Process for CAR T

Webinar LV Process for CAR T

Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.

Ready to discuss your GMP path?

Our experts are only a message away to help you understand the impact of any choices and to inform decision-making.

We’d be happy to discuss and help you bring Cell and Gene Therapies to patients.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Cleanroom Rental

Consultancy

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

About Us

Partners

History

Facility

Ecosystem